Clinical trial
Electrophysiologically Guided PAcing Site Selection Study
NCT00239226 · Medtronic BRC, Industry · Completed
Key facts
| NCT number | NCT00239226 |
|---|---|
| Title | Electrophysiologically Guided PAcing Site Selection Study |
| Official title | Investigational New Drug Application/ Investigational Device Exemption Information |
| Acronym | EPASS |
| Lead sponsor | Medtronic BRC, Industry |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sinus Arrhythmia, Atrial Fibrillation |
| Intervention type | Procedure |
| Interventions | IAS pacing - study group, IAS pacing control group, Pacing RAA study group, Pacing RAA control group |
| Enrollment | 102 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Oct 14, 2005 |
| Last update posted | Nov 25, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: